| pubmed-article:7815656 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C0001175 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C0043474 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C0018759 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C0012132 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C0282440 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C1096777 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
| pubmed-article:7815656 | lifeskim:mentions | umls-concept:C0449435 | lld:lifeskim |
| pubmed-article:7815656 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:7815656 | pubmed:dateCreated | 1995-2-9 | lld:pubmed |
| pubmed-article:7815656 | pubmed:abstractText | To evaluate the functional and health status implications of prescribing zalcitabine or zidovudine for initial therapy of acquired immunodeficiency syndrome (AIDS). | lld:pubmed |
| pubmed-article:7815656 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7815656 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7815656 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7815656 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7815656 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7815656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7815656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7815656 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7815656 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:7815656 | pubmed:issn | 0098-7484 | lld:pubmed |
| pubmed-article:7815656 | pubmed:author | pubmed-author:BerrySS | lld:pubmed |
| pubmed-article:7815656 | pubmed:author | pubmed-author:BozzetteS ASA | lld:pubmed |
| pubmed-article:7815656 | pubmed:author | pubmed-author:DuanNN | lld:pubmed |
| pubmed-article:7815656 | pubmed:author | pubmed-author:KanouseD EDE | lld:pubmed |
| pubmed-article:7815656 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7815656 | pubmed:day | 25 | lld:pubmed |
| pubmed-article:7815656 | pubmed:volume | 273 | lld:pubmed |
| pubmed-article:7815656 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7815656 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7815656 | pubmed:pagination | 295-301 | lld:pubmed |
| pubmed-article:7815656 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:meshHeading | pubmed-meshheading:7815656-... | lld:pubmed |
| pubmed-article:7815656 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7815656 | pubmed:articleTitle | Health status and function with zidovudine or zalcitabine as initial therapy for AIDS. A randomized controlled trial. Roche 3300/ACTG 114 Study Group. | lld:pubmed |
| pubmed-article:7815656 | pubmed:affiliation | Health Sciences Program, RAND, Santa Monica, CA 90407-2138. | lld:pubmed |
| pubmed-article:7815656 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7815656 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7815656 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7815656 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:7815656 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:7815656 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7815656 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7815656 | lld:pubmed |
